ArticleNature communications2026
Magnetic-driven multifunctional optoelectronic catheter for in vivo chemical mapping and precisely guided-tumor therapy.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Precision tumor theranostic in minimally invasive interventions still face challenges such as poor navigational flexibility and limited functional integration. Here, we present a 2.5 mm magnetic-driven multifunctional optoelectronic catheter (MDMOC) fabricated via 3D multi-axis printing for in situ tumor mapping and therapy. The MDMOC integrates magnetic navigation, targeted drug delivery, localized photodynamic therapy, X-ray trackable imaging, and multiplexed biosensing of metabolites and ions. Its magneto-optical-electric-fluid multimodal design enables navigation through complex pathways, simultaneously monitoring biomarkers across the tumor microenvironment and delivering localized therapy. In rabbit and mouse tumor models, the MDMOC distinguished tumor from normal tissue, guided precise therapy, and minimized systemic side effects. In a Bama pig model, it achieved accurate navigation, multiparametric sensing, and targeted contrast agent delivery in complex anatomy. By integrating diagnostic and therapeutic functions with remote magnetic control, the MDMOC provides a versatile platform for real-time, precision-guided tumor diagnosis and therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.